UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-density lipoproteins, reverse cholesterol transport and atherogenesis

Nature reviews cardiology, 2021-10, Vol.18 (10), p.712-723

2021

Volltextzugriff (PDF)

Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases

Journal of cellular physiology, 2018-12, Vol.233 (12), p.9237-9246

2018

Volltextzugriff (PDF)

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

The American journal of pathology, 2013-05, Vol.182 (5), p.1474-1481

2013

Volltextzugriff (PDF)

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

The New England journal of medicine, 2009-04, Vol.360 (18), p.1851-1861

2009

Volltextzugriff (PDF)

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

The New England journal of medicine, 2008-11, Vol.359 (21), p.2195-2207

2008

Volltextzugriff (PDF)

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

The Lancet (British edition), 2009-04, Vol.373 (9670), p.1175-1182

2009

Volltextzugriff (PDF)

Serum opacity factor rescues fertility among female Scarb1−/− mice by reducing HDL-free cholesterol bioavailability

Journal of lipid research, 2023-02, Vol.64 (2), p.100327-100327, Article 100327

2023

Volltextzugriff (PDF)

Serum Opacity Factor Normalizes Erythrocyte Morphology in Scarb1-/- Mice in an HDL-Free Cholesterol-Dependent Way

Journal of lipid research, 2023-11, Vol.64 (11), p.100456-100456, Article 100456

2023

Volltextzugriff (PDF)

Atherosclerosis risk classification with computed tomography angiography: A radiologic-pathologic validation study

Atherosclerosis, 2023-02, Vol.366, p.42-48

2023

Volltextzugriff (PDF)

PCSK9 and inflammation: a review of experimental and clinical evidence

European heart journal. Cardiovascular pharmacotherapy, 2019-10, Vol.5 (4), p.237-245

2019

Volltextzugriff (PDF)

Inflammation in atherosclerosis and implications for therapy

Circulation (New York, N.Y.), 2004-06, Vol.109 (23 Suppl 1), p.III20-III26

2004

Volltextzugriff (PDF)

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

The American journal of cardiology, 2012-07, Vol.110 (1), p.3A-14A

2012

Volltextzugriff (PDF)

Pharmacotherapies for lipid modification: beyond the statins

Nature reviews cardiology, 2013-10, Vol.10 (10), p.560-570

2013

Volltextzugriff (PDF)

Statin Intolerance: the Clinician’s Perspective

Current atherosclerosis reports, 2015-12, Vol.17 (12), p.69-69, Article 69

2015

Volltextzugriff (PDF)

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

The New England journal of medicine, 2001-06, Vol.344 (26), p.1959-1965

2001

Volltextzugriff (PDF)

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials

Diabetes, obesity & metabolism, 2022-05, Vol.24 (5), p.868-880

2022

Volltextzugriff (PDF)

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

JAMA : the journal of the American Medical Association, 2012-03, Vol.307 (12), p.1302

2012

Volltextzugriff (PDF)

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

The American journal of cardiology, 2014, Vol.113 (1), p.76-83

2014

Volltextzugriff (PDF)

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

The American journal of pathology, 2019-03, Vol.189 (3), p.492-501

2019

Volltextzugriff (PDF)

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.717-724

2004

Volltextzugriff (PDF)

Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

Pharmacological research, 2018-06, Vol.132, p.232-241

2018

Volltextzugriff (PDF)

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

JAMA cardiology, 2020-10, Vol.5 (10), p.1124

2020

Volltextzugriff (PDF)

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

The Lancet (British edition), 2010-07, Vol.376 (9738), p.333-339

2010

Volltextzugriff (PDF)

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

The American journal of cardiology, 2012-07, Vol.110 (1), p.15A-26A

2012

Volltextzugriff (PDF)

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association

Journal of clinical lipidology, 2017-07, Vol.11 (4), p.880-890

2017

Volltextzugriff (PDF)

1 – 25 von 670

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(528)
Mit Volltextzugriff
(573)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(670)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(370)
Humans
(363)
Life Sciences & Biomedicine
(356)
Biological And Medical Sciences
(144)
Male
(131)
Cardiovascular System & Cardiology
(116)
Medical Sciences
(116)
Cardiac & Cardiovascular Systems
(112)
Female
(108)
Biochemistry & Molecular Biology
(101)
Middle Aged
(92)
Animals
(87)
Cholesterol
(83)
Risk Factors
(78)
Adult
(71)
Cardiovascular Disease
(69)
General & Internal Medicine
(67)
Medicine, General & Internal
(67)
Cholesterol, Ldl - Blood
(61)
Aged
(59)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High-density lipoproteins, reverse cholesterol transport and atherogenesis

Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Serum opacity factor rescues fertility among female Scarb1−/− mice by reducing HDL-free cholesterol bioavailability

Serum Opacity Factor Normalizes Erythrocyte Morphology in Scarb1-/- Mice in an HDL-Free Cholesterol-Dependent Way

Atherosclerosis risk classification with computed tomography angiography: A radiologic-pathologic validation study

PCSK9 and inflammation: a review of experimental and clinical evidence

Inflammation in atherosclerosis and implications for therapy

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

Pharmacotherapies for lipid modification: beyond the statins

Statin Intolerance: the Clinician’s Perspective

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association

Aktive Filter

Suchergebnisse filtern